Merck , known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 CORALreef Lipids trial demonstrating that treatment with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback